Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 2012 Feb; 109 Suppl 1:22-9.

View in: PubMed

subject areas

Brachytherapy
Disease Progression
Disease-Free Survival
Humans
Male
Neoplasm Staging
Prostatectomy
Prostate-Specific Antigen
Prostatic Neoplasms
Risk Factors
Survival Rate

authors with profiles

STEVEN JAY FRANK